Fundz

Who to call at Baxter International Inc., and when

Fundz watches for the moments Baxter International Inc. starts buying, and tells you who to reach.

  • An alert the day Baxter International Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Baxter International Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Baxter International Inc.. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KMEDIUM RiskNegative

Baxter International Inc.

A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.

baxterinternational.in
Filed: Nov 12, 2025CIK: 0000010456Manufacturing
Full company profileView on SEC.gov

Leadership shakeup: 3 executive changes at Baxter International in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.

The seat is still open. No replacement has been named 347 days after this filing.

See every company with multiple executive changes →

AI Executive Summary

AI-powered analysis of 8-K filing content

Baxter International's Executive Vice President and Group President, Pharmaceuticals, Alok Sonig, resigned effective December 1, 2025, to join a healthcare company. The departure removes a senior leader of one of Baxter's two main business groups during a period of leadership change.

Key Takeaways

Alok Sonig, EVP and Group President, Pharmaceuticals, gave notice on November 5, 2025, with his resignation effective December 1, 2025.

Sonig is departing to join another company in the healthcare industry, according to the filing. The filing does not describe the reasons for the decision.

3 more takeaways

Related Filings (17)

17 more filings from Baxter International Inc. in the last 90 days

Filing Overview

Form Type8-K
Filing DateNov 12, 2025
Item5.02
CategoryExecutive Change
CIK0000010456
Accession #0001628280-25-051371
Risk LevelMEDIUM
SentimentNegative
Signalrisk
Topics
executive departureleadership transition

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

Baxter International Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.